Quotient Wealth Partners’s AstraZeneca AZN Stock Holding History

Quotient Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Sell	1,246 -425	-25%	-$79.9K	0.01%	359
2026 Q1	$330K	Buy	1,671 +169	+11%	+$32.6K	0.01%	265
2025 Q4	$276K	Sell	1,502 -64	-4%	-$11.2K	0.01%	290
2025 Q3	$240K	Sell	1,566 -242	-13%	-$36.6K	0.01%	317
2025 Q2	$253K	Sell	1,808 -268	-13%	-$37.6K	0.01%	302
2025 Q1	$305K	Sell	2,076 -436	-17%	-$63.1K	0.01%	256
2024 Q4	$329K	Sell	2,512 -382	-13%	-$53.5K	0.01%	231
2024 Q3	$451K	Buy	2,894 +113	+4%	+$18.2K	0.01%	186
2024 Q2	$434K	Buy	2,781 +1,123	+68%	+$169K	0.02%	188
2024 Q1	$225K	Buy	+1,658	New	+$220K	0.01%	282

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quotient Wealth Partners's AZN Position: Q2 2026 in Review

Quotient Wealth Partners reduced its AstraZeneca (AZN) stake by 25% in Q2 2026, selling an estimated $79.9K and leaving 1,246 shares worth $236K. The position accounts for 0.01% of the portfolio, ranked #359.

Quotient Wealth Partners first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. The position peaked at $451K in Q3 2024. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Quotient Wealth Partners held 1,246 shares of AstraZeneca worth $236K as of Q2 2026.
Quotient Wealth Partners sold 425 AstraZeneca shares in Q2 2026, an estimated $79.9K.
AstraZeneca made up 0.01% of Quotient Wealth Partners's portfolio in Q2 2026, its #359 holding.
Quotient Wealth Partners first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
Quotient Wealth Partners's AstraZeneca position peaked at $451K in Q3 2024.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.